A Study of LY3493269 in Participants With Type 2 Diabetes

Clinical trial NCT04515576 · COMPLETED

Trial details

NCT number: NCT04515576
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2020-08-25
Primary completion: 2021-03-09
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.